Literature DB >> 116084

Familial hyperlysinaemia due to L-lysine alpha-ketoglutarate reductase deficiency: results of attempted treatment.

C vd Heiden, M Brink, P K de Bree, F J v Sprang, S K Wadman, J M de Pater, J P van Biervliet.   

Abstract

A mentally retarded male infant with persistent hyperlysinaemia due to L-lysine alpha-ketoglutarate reductase deficiency is described. The effect of dietary restriction of lysine on his mental and behavioural development was examined. By restricting daily dietary lysine to 5.5 mg/kg body weight the fasting serum lysine became normal. Urinary lysine also became normal and the secondary metabolites homocitrulline, homoarginine, N alpha-acetyllysine and N epsilon-acetyllysine were no longer detected. After control of serum lysine for 2.5 y it was felt that the patient's social behaviour, but not his mental development, had improved somewhat.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 116084     DOI: 10.1007/bf01805679

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  21 in total

1.  HYPERLYSINEMIA.

Authors:  N C WOODY
Journal:  Am J Dis Child       Date:  1964-11

2.  [Direct determination of ammonium in blood and tissue extracts by means of the phenol by chlorite reaction].

Authors:  K KONITZER; S VOIGT
Journal:  Clin Chim Acta       Date:  1963-01       Impact factor: 3.786

3.  Periodic hyperammonemia, hyperlysinemia, and homocitrullinuria associated with decreased argininosuccinate synthetase and arginase activities.

Authors:  H Sogawa; K Oyanagi; T Nakao
Journal:  Pediatr Res       Date:  1977-09       Impact factor: 3.756

4.  Enzyme studies in a patient with saccharopinuria: a defect of lysine metabolism.

Authors:  F C Fellows; N A Carson
Journal:  Pediatr Res       Date:  1974-01       Impact factor: 3.756

5.  Hyperlysinemia associated with retardation.

Authors:  H Ghadimi; V I Binnington; P Pecora
Journal:  N Engl J Med       Date:  1965-09-30       Impact factor: 91.245

6.  A case of hyperlysinemia: biochemical and clinical observations.

Authors:  M D Armstrong; M Robinow
Journal:  Pediatrics       Date:  1967-04       Impact factor: 7.124

7.  Further studies of hyperlysinemia.

Authors:  N C Woody; J Hutzler; J Dancis
Journal:  Am J Dis Child       Date:  1966-12

8.  Paths of lysine degradation in patients with hyperlysinemia.

Authors:  N C Woody; E B Ong
Journal:  Pediatrics       Date:  1967-12       Impact factor: 7.124

9.  N-EPSILON-(CARBOXYMETHYL)LYSINE, A CONSTITUENT OF HUMAN URINE.

Authors:  S K Wadman; P K De Bree; F J Van Sprang; J P Kamerling; J Haverkamp; J F Vliegenthart
Journal:  Clin Chim Acta       Date:  1975-03-24       Impact factor: 3.786

10.  Clinical and biochemical studies on periodic hyperammonemia with hyperlysinemia and homocitrullinuria.

Authors:  K Oyanagi; H Sogawa; S Sato; T Orii; T Nakao
Journal:  Tohoku J Exp Med       Date:  1976-10       Impact factor: 1.848

View more
  5 in total

Review 1.  Biosynthesis, degradation and pharmacological importance of the fatty acid amides.

Authors:  Emma K Farrell; David J Merkler
Journal:  Drug Discov Today       Date:  2008-04-03       Impact factor: 7.851

2.  Studies on the pathway from ornithine to proline in cultured skin fibroblasts with reference to the defect in hyperornithinaemia with hyperammonaemia and homocitrullinuria.

Authors:  R G Gray; S E Hill; R J Pollitt
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

3.  The prognosis of hyperlysinemia: an interim report.

Authors:  J Dancis; J Hutzler; M G Ampola; V E Shih; H H van Gelderen; L T Kirby; N C Woody
Journal:  Am J Hum Genet       Date:  1983-05       Impact factor: 11.025

4.  Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1.

Authors:  João Leandro; Susmita Khamrui; Chalada Suebsuwong; Peng-Jen Chen; Cody Secor; Tetyana Dodatko; Chunli Yu; Roberto Sanchez; Robert J DeVita; Sander M Houten; Michael B Lazarus
Journal:  Open Biol       Date:  2022-09-21       Impact factor: 7.124

5.  Genetic basis of hyperlysinemia.

Authors:  Sander M Houten; Heleen Te Brinke; Simone Denis; Jos Pn Ruiter; Alida C Knegt; Johannis Bc de Klerk; Persephone Augoustides-Savvopoulou; Johannes Häberle; Matthias R Baumgartner; Turgay Coşkun; Johannes Zschocke; Jörn Oliver Sass; Bwee Tien Poll-The; Ronald Ja Wanders; Marinus Duran
Journal:  Orphanet J Rare Dis       Date:  2013-04-09       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.